GlassScriptPhysician profile
Nawar Mansour
NPI 1720077589
$1,093.39
in general payments reported to CMS, 2019-2025
9 companies · $9.02 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $81.94 · 2021: $122 · 2022: $669 · 2023: $28.53 · 2024: $58.58 · 2025: $9.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $79.92 · Food and Beverage: $16.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $79.92 |
| Food and Beverage | $16.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $236.77 | 2021-2022 | |
| Glaxosmithkline, LLC. | $234.09 | 2022-2023 | Benlysta |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $118.71 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $116.59 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $100.37 | 2022 | |
| Vifor Pharma, INC. | $81.94 | 2020 | |
| Travere Therapeutics, INC. | $55.31 | 2023-2025 | Filspari |
| Akebia Therapeutics INC | $24.61 | 2024 | Vafseo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nawar Mansour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.